Fully integrated biopharmaceutical solutions organization Syneos Health announced the appointment of two new independent directors, Barbara W. Bodem and Alfonso G. Zulueta, to its Board of Directors.
If you are not happy with the results below please do another search
50 search results for:
Healthline Media launched a suite of seven health condition communities through its new brand, Bezzy.
Endo International agreed to pay up to $65 million to resolve claims by the state of Florida and local governments that the drugmaker helped fuel the U.S. opioid epidemic.
Merck & Co. Inc. and partner Ridgeback Biotherapeutics LP said on January 18 they had signed an agreement with the United Nations Children’s Fund (UNICEF) to supply up to 3 million courses of their COVID-19 antiviral pill.
To alleviate the problem of antibiotic-resistant bacteria, or superbugs, several biotechnology companies are developing different strategies to target and kill these microorganisms.
Moderna Inc.’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Jan. 17.
Speaking with French newspaper Le Figaro, Pfizer Chief Executive Officer Albert Bourla said he believes the world will “return to normal life” sometime during the spring of 2022.
A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a preliminary study in Israel.
Building on Novo Nordisk’s success during June 2021 in obtaining the first drug approval for weight management since 2014, the Danish pharma giant is partnering with biotech company EraCal Therapeutics to develop new obesity-related drug targets.
GlaxoSmithKline declined all three of Unilever’s offers to acquire GSK’s consumer healthcare business, saying the proposal undervalued the division’s present and further worth.